Photodynamic Alzheimer's disease therapy: From molecular catalysis to photo-nanomedicine

Xu Y.; Zhang B.; Xie J.Zhang H.Xiong H.Lee I.Li M.Seung Kim J.

首页> 外文期刊>Coordination chemistry reviews >Photodynamic Alzheimer's disease therapy: From molecular catalysis to photo-nanomedicine

【24h】

Photodynamic Alzheimer's disease therapy: From molecular catalysis to photo-nanomedicine

机译：Photodynamic Alzheimer's disease therapy: From molecular catalysis to photo-nanomedicine

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

? 2022 Elsevier B.V.Alzheimer's disease (AD) is a major form of dementia, closely associated with the filamentous assembly of amyloid-β (Aβ) and Tau protein in the brain, which can cause memory and learning deficits. Over the world, developing available AD drugs has been considered as one of the major goals in AD research not only for pharmacology but also for chemistry and biomedicine. However, current strategies to treat AD disease are mainly based on chemotherapy, while very limited AD drugs have been approved by FDA. As an alternative, recently great efforts have been dedicated to employing the photodynamic therapy (PDT) approach to intervene the AD-related protein (e.g., amyloid-β and Tau) aggregations via photon-triggered reactive oxygen species generation. Although photodynamic AD therapy remains in its infancy and many concerns need to be dissolved, it is still believed to serve as a promising alternative to reverse the dilemma of Alzheimer's treatment. With this hope in mind, here we aim to draw a blueprint for this emerging area. In this review, we not only summarize the photochemical principles of AD therapy and the states-of-the-art photodynamic molecules/photo-nanomedicine that are capable of regulating the AD pathological proteins, but also, also the most important, overview the pros and cons of photodynamic AD therapy and give some suggestions for overcoming the challenges in this field. It is our hope that the progress made to date, as summarized in this paper, can inspire future efforts to seek out more promising photochemical approaches, better fitting the clinical requirements of AD therapy.

著录项

来源
《Coordination chemistry reviews》 |2022年第11期|214726.1-214726.21|共21页
作者
Xu Y.; Zhang B.; Xie J.Zhang H.Xiong H.Lee I.Li M.Seung Kim J.;
展开▼
作者单位

SZU-NUS Collaborative Innovation Center for Optoelectronic Science & Technology Institute of Microscale Optoelectronics and Translational Medicine First Affiliated Hospital (Shenzhen Second People's Hospital);

International Collaborative Laboratory of 2D Materials for Optoelectronics Science and Technology of Ministry of Education College of Physics and Optoelectronic Engineering Shenzhen University||Department of Chemistry Korea University;

International Collaborative Laboratory of 2D Materials for Optoelectronics Science and Technology of Ministry of Education College of Physics and Optoelectronic Engineering Shenzhen University;

展开▼
收录信息美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);
原文格式 PDF
正文语种英语
中图分类
关键词
Alzheimer's disease; Amyloid-β; Photo-nanomedicine; Photodynamic therapy; Tau protein;

Photodynamic Alzheimer's disease therapy: From molecular catalysis to photo-nanomedicine

摘要

著录项

相关主题

期刊订阅